Department of Nutrition and Food Hygiene, School of Public Health, Soochow University, Suzhou, China.
Independent scientist, Irving, Texas,United States.
Nutrition. 2022 Mar;95:111558. doi: 10.1016/j.nut.2021.111558. Epub 2021 Nov 28.
Gut microbiota-derived metabolites are involved in intestinal inflammation, which can affect the development of atherosclerotic plaques. Previous studies have shown that oat fiber can delay the progression of atherosclerosis via improving lipid metabolism. The aim of this study was to evaluate how oat fiber acted on gut microbiota-derived metabolites, inhibited intestinal inflammation, and protected the intestinal mucosal barrier.
Male low-density lipoprotein receptor knock-out (LDLR) mice were fed a high-fat/cholesterol diet with or without oat fiber for 14 wk. Histopathology of the aorta was detected by Oil Red O staining, and the small intestine mucosal pathology was measured through hematoxylin and eosin staining. Non-targeted metabolomics of feces was performed using liquid chromatography-mass spectrometry. Western blot method was used to assess the relative levels of the proteins involved in the toll-like receptor (TLR)4 signal pathway and intestinal mucosal barrier in interest tissues.
Pathologically, oat fiber reversed the increment of the atherosclerotic lesion and ameliorated intestinal mucosal barrier in LDLR mice. Oat fiber regulated the levels of gut microbiota-derived metabolites along with a decrease in isobutyrylcarnitine, valerylcarnitine, 1-methylguanosine, and 2-methylguanosine, and an increase in l-tyrosine and niacinamide. Notably, oat fiber blocked the TLR4 signal pathway and decreased the expression of nuclear factor-κB p65 in both the aorta and gut tissues. Also, oat fiber raised the expression of tight junction proteins including ZO-1 and occludin.
Taken together, the present study revealed that oat fiber feeding effectively attenuated the development of atherosclerosis, at least partly via affecting gut microbiota-derived metabolites, inhibiting the intestinal inflammatory response, and maintaining the integrity of the intestinal mucosal barrier.
肠道微生物衍生代谢物参与肠道炎症,从而影响动脉粥样硬化斑块的发展。先前的研究表明,燕麦纤维可以通过改善脂质代谢来延缓动脉粥样硬化的进展。本研究旨在评估燕麦纤维如何作用于肠道微生物衍生代谢物,抑制肠道炎症,保护肠道黏膜屏障。
雄性低密度脂蛋白受体敲除(LDLR)小鼠喂食高脂肪/胆固醇饮食,同时或不喂食燕麦纤维,共 14 周。油红 O 染色检测主动脉组织病理学,苏木精和伊红染色检测小肠黏膜病理。采用液相色谱-质谱联用技术进行粪便非靶向代谢组学分析。Western blot 法检测 TLR4 信号通路相关蛋白和肠道黏膜屏障在感兴趣组织中的相对水平。
病理结果显示,燕麦纤维逆转了 LDLR 小鼠的动脉粥样硬化病变程度并改善了肠道黏膜屏障。燕麦纤维调节了肠道微生物衍生代谢物的水平,使异丁酰肉碱、缬酰肉碱、1-甲基鸟苷和 2-甲基鸟苷的水平降低,而 l-酪氨酸和烟酰胺的水平升高。值得注意的是,燕麦纤维阻断了 TLR4 信号通路,并降低了主动脉和肠道组织中核因子-κB p65 的表达。此外,燕麦纤维增加了紧密连接蛋白 ZO-1 和 occludin 的表达。
综上所述,本研究表明,燕麦纤维喂养可有效减轻动脉粥样硬化的发展,至少部分是通过影响肠道微生物衍生代谢物、抑制肠道炎症反应和维持肠道黏膜屏障的完整性来实现的。